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The present study is designed to investigate the effect of an anti-obesity functional formula (PMC) 
composed of Prumus mume stem barks extract (PMSBE) and L-carnitine (2:1, w/w) on obesity and 
hyperlipidemia induced by high-fat diet in mice. Male ICR mice were fed a high-fat diet (HFD) with or 
without PMC (PMC-1 group: 450 mg/kg/day; PMC-2 group: 900 mg/kg/day) for 6 weeks to examine 
adipose tissue weight, serum lipid profile, and the pathological changes in liver tissue. The results 
showed that body weight gain was significantly lowered in PMC groups compared with the HFD group. 
PMC could improve lipid profile by lowering serum total cholesterol (Total-C), triacylglycerol (TG), 
low-density lipoprotein cholesterol (LDL-C) concentrations, and increasing high-density lipoprotein 
cholesterol (HDL-C) concentration as compared with the HFD group. PMC also improved the 
pathological changes in liver tissue, decreased the relative weights of epididymal and perirenal WAT. 
Our findings suggest that PMC has significantly anti-obesity and hypolipidemic effects. 
 





Obesity is one of the greatest health threats of this 
century, which has an important impact on life 
style-related diseases such as coronary heart disease, 
dyslipidemia, glucose intolerance, diabetics, hypertension 
and some cancers (Hu et al., 2008). Several factors, 
including lack of exercise, sedentary lifestyles and the 
consumption of energy rich diets are contributory to the 
etiology of obesity (Ekanem et al., 2007). Despite  the  
urgent need for safe  
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and efficient therapeutics and the potential size of the 
market for anti-obesity drugs, the current status for the 
development of such drugs is still unsatisfactory 
(Shrestha et al., 2007). Some edible medicinal plants 
have been used as dietary supplements for body-weight 
management and control in many countries (Bagri et al., 
2009; Lee et al., 2008). 
Mei (Prunus mume Sieb. et Zucc.) is a deciduous tree 
of Rosaceae family, which originated in Southeastern 
China and grown widely (Jo et al., 2006; Ning et al., 2007). 
The stem bark of P. mume is used as herbal medicines in 
several Asia countries (Matsuda et al., 2003). The stem 
bark extract of P. mume showed 28.4% inhibition of NO 
production in LPS-activated macrophages at the 
concentration of 80 g/mL of sample in culture media 
(Ryu et al., 2003). There is no more information on the 
bioactive components and modern pharmacological 
effects of P. mume stem bark. 
L-Carnitine is a small, water-soluble, quaternary amine 
that plays an important role in lipid catabolism in 
mammals (Lee et al., 2006; Yang et al., 2006).  




Supplementation of L-carnitine and antioxidants could 
lower plasma lipid concentrations and serum glucose, 
insulin and leptin levels in rats with HFD-induced obesity 
(Kim et al., 2008). P. mume stem bark extract combined 
with L-carnitine may have the latent capacity to reduce 
body fat and serum lipids in obese mammals.  
The objective of this study was to investigate the effect 
of an anti-obesity functional formula (PMC) composed of 
P. mume stem barks extract and L-carnitine on obesity 
and hyperlipidemia induced by high-fat diet in mice. 
 
 
MATERIALS AND METHODS 
 
Preparation of P. mume stem bark extract (PMSBE) and 
powdered anti-obesity functional formula (PMC) 
 
The stem bark of P. mume were obtained from a farm in Xiaoshan 
district (Hangzhou, Zhejiang province), air-dried, ground and 
extracted three times with 30% ethanol at 80°C for 3 h each, then 
extracts were filtered using a strainer and spray-dried.  
The anti-obesity functional formula (PMC) was prepared 
according to the project with New Era Health Industry (Group) Co., 
Ltd., China. The dried powder of P. mume stem barks extract 
(PMSBE) was passed through 40-mesh sieves. L-Carnitine was 
purchased from Jiangyin Haida Fine Chemical Plant (China). PMC 




Determining total phenolics and total flavonoids contents in 
PMSBE 
 
The amount of phenolic compounds in PMSBE was determined by 
the modified Folin-Ciocalteu method (Jimoh et al., 2007), and was 
expressed as milligrams of gallic acid equivalents (GAE) per g of 
PMSBE.  
The flavonoids content in PMSBE was measured using a 
colorimetric assay developed by Pourmorad et al. (2006), and was 





The experimental diets consisted of: normal diet (ND), purchased 
from Shanghai SLAC Laboratory Animal Co., Ltd.; high-fat diet (HFD: 
ND supplemented with 10% egg yolk power and 10% lard), 
processed by Zhejiang Academy of Medical Sciences. 
Fifty 7-week-old male ICR mice were obtained from Shanghai 
SLAC Laboratory Animal Co., Ltd. Mice were acclimated to the 
experimental facility for 1 week before they were divided into five 
groups of ten and housed in polycarbonate cages in a room 
maintained at 23 ± 1°C and 55 ± 5% relative humidity. The room 
was exposed to alternating 12-h periods of light and dark. Ten mice 
(normal group) had free access to standard pelleted chow (normal 
diet, ND; Shanghai, China), and simultaneously administrated with 
deionized water at a dose of 10 mL/kg/day (orally) for 6 weeks. The 
remaining 40 mice were fed with a high-fat diet (HFD: ND 
supplemented with 10% egg yolk power and 10% lard) and 
randomly divided into 4 groups of HFD, HFD+PMC-1, HFD+PMC-2 
and HFD+OR (orlistat). The HFD group simultaneously 
administrated with deionized water at a dose of 10 mL/kg/day (orally) 
for 6 weeks as ND group. The HFD+PMC-1, HFD+PMC-2 and 
HFD+OR groups simultaneously administrated with PMC (450 
mg/kg/day, orally), PMC (900 mg/kg/day, orally), and orlistat (50 
mg/kg/day, orally) for 6 weeks, respectively. The energy level of the 





in the normal group was 360 kcal/100 g. The animals were given 
food and distilled water ad libitum during the experimental period. 
Food consumption and body weight gain were measured every 
week. 
At the end of the experimental period, mice were sacrificed 
following a 14-h fast and collecting blood samples. The serum was 
separated by centrifugation at 3,000 rpm for 15 min and stored at - 
86°C in order to determine the serum lipid profile. Livers were 
removed with the animals under anesthesia and rinsed with cold 
physiological saline and weighted, immediately frozen in liquid 
nitrogen and stored at -86°C for further analysis. The adipose 
tissues (epididymal WAT and perirenal WAT) were immediately 
weighed. This investigation involving mice was carried out in 
accordance with the University Animal Care and Use Committee 
guidelines at Zhejiang University. 
 
 
Quantitation of serum biochemical parameters 
 
The concentrations of serum Total-C, TG, and HDL-C were assayed 
enzymatically using commercial kits (Nanjing Jiancheng 
Bioengineering Institute, Nanjing, China). LDL-C was calculated 
from triglyceride, total cholesterol, and HDL-C concentrations using 
the following Friedwald formula (Friedewald et al., 1972):  
 





Livers were removed from the mice and fixed in a buffer solution of 
10% formalin. Fixed tissues were processed routinely for paraffin 
embedding, and 4 m sections were prepared and dyed with 
hematoxylineosin; stained areas were viewed using an optical 





The data for the mice were expressed as means ± S.E.M. All 
statistical analyses were performed using SPSS 13.0 statistical 
software. Significant differences among the treatment means were 
determined using analysis of variance (ANOVA) and Duncan’s 
multiple range test. Results were considered to be statistically 





Total phenolics and total flavonoids contents of 
PMSBE 
 
The total phenolics content of PMSBE was 401.0 mg/g, 




Body weight and food intake 
 
As shown in Table 1, body weight gain of the HFD group 
mice were considerably higher than the other groups. The 
weight gain of PMC-1, PMC-2 and OR groups were 
normalized to the ND group. Feed intake of all 
experimental groups had no significantly different. 








ND HFD OR PMC-1 PMC-2 
Initial body weight (g) 22.73 ± 0.19 22.79 ± 0.21 22.07 ± 0.28 21.94 ± 0.39 22.41± 0.24 
Final body weight (g) 35.53 ± 0.78 ab 38.17 ± 1.01 a 34.08 ± 1.24 b 34.40 ± 0.84 b 35.06 ± 0.98 ab 
Body weight gain (g/day) 0.29 ± 0.02 b 0.35 ± 0.02 a 0.27 ± 0.03 b 0.28 ± 0.02 b 0.29 ± 0.03 b 
 
Values are mean ± S.E.M.; n = 10 in each group.  
abMeans in the same row not sharing a common superscript are significantly different (P < 0.05) between groups.  
ND, Normal control group; HFD, high-fat diet group; OR, high-fat diet with orlistat group; PMC-1, high-fat diet with PMC (450 




Table 2. Effects of PMC on liver and adipose tissue weights in mice fed high-fat diet. 
 
Tissue 
Weight ratio (mg/g of body weight) 
ND HFD OR PMC-1 PMC-2 
Liver 31.87 ± 2.09 36.31 ± 1.70 31.30 ± 1.48 32.21 ± 1.39 33.82 ± 1.28 
Adipose tissue      
Epididymal WAT 15.13 ± 1.54 c 30.35 ± 2.74 a 20.43 ± 1.98 bc 25.12 ± 2.03 ab 22.51 ± 1.73 b 
Perirenal WAT 2.78 ± 0.36 b 8.89 ± 0.95 a 5.89 ± 0.76 b 7.30 ± 0.96 ab 5.51 ± 0.39 b 
Total 17.92 ± 1.82 c 39.26 ± 3.49 a 26.33 ± 2.59 b 32.41 ± 2.91 ab 28.02 ± 1.99 b 
 
Values are mean ± S.E.M.; n = 10 in each group.  
a - cMeans in the same row not sharing a common superscript are significantly different (P < 0.05) between groups.  





Table 3. Effects of PMC on lipids concentrations in serum. 
 
Lipid 
Lipid levels in different groups 
ND HFD OR PMC-1 PMC-2 
Total-C (mmol/L) 2.81 ± 0.08 c 4.75 ± 0.23 a 4.14 ± 0.14 b 4.04 ± 0.17 b 3.84 ± 0.14 b 
TG (mmol/L) 1.13 ± 0.11 b 1.50 ± 0.08 a 1.00 ± 0.06 b 1.24 ± 0.07 b 1.14 ± 0.07 b 
HDL-C (mmol/L) 1.09 ± 0.02 a 0.94 ± 0.02 c 1.03 ± 0.02 b 1.04 ± 0.02 ab 1.05 ± 0.02 ab 
LDL-C (mmol/L) 1.50 ± 0.08 c 3.51 ± 0.22 a 2.91 ± 0.14 b 2.76 ± 0.17 b 2.56 ± 0.13 b 
HDL-C/ Total-C 0.39 ± 0.01 a 0.20 ± 0.01 c 0.25 ± 0.01 b 0.26 ± 0.01 b 0.27 ± 0.01 b 
LDL-C/ Total-C 0.53 ± 0.01 c 0.74 ± 0.01 a 0.70 ± 0.01 ab 0.68 ± 0.01 b 0.66 ± 0.01 b 
 
Values are mean ± S.E.M.; n = 10 in each group.  
a-cMeans in the same row not sharing a common superscript are significantly different (P < 0.05) between groups.  




Liver and adipose tissues weights 
 
Liver and adipose tissues weights were expressed as 
relative weight per body weight (Table 2). The relative 
weight of the liver had no significantly higher in the HFD 
group compared with other groups. The relative weight of 
the epididymal WAT and perirenal WAT were significantly 
lower in the ND, OR, PMC-1, or PMC-2 group than in the 
HFD group. Overall, the supplementation with PMC (orally) 
resulted in significantly lower weights of WAT compared 
to that of the HFD group. 
Serum lipid levels 
 
Concentrations of serum lipids are shown in Table 3. PMC 
and OR significantly lowered the serum Total-C concen- 
tration, TG concentration, LDL-C concentration, and the 
ratio of LDL-C/ Total-C compared to the HFD group. 
Supplementation of oral PMSBEC or OR exhibited a trend 
towards increased serum HDL-C levels, compared to 
HFD group, and the ratio of HDL-C/ Total-C exhibited 
higher values in the PMC-1, PMC-2 or OR group than in 
the HFD group.  






Figure 1. Effects of PMC on the liver tissue. Histological analysis of livers treated with HFD, HFD+OR, HFD+PMC-1 and 
HFD+PMC-2. Liver sections were stained with hematoxylin and eosin. Magnification ×400. See Table 1 for a description of the 




Effects of PMC on the liver 
 
The livers in the HFD group were enlarged and produced 
a yellowish color, indicating liver steatosis. On the 
contrary, administration of PMC or OR reversed the liver 
to remain red and healthy. As shown in Figure 1, in 
histological  
analysis, the liver of HFD-treated mice exhibited a typical 
sign of fatty liver showing the accumulation of many fat 
droplets and tissues through the liver acini. When mice 
were treated with PMC or OR, however, a much smaller 
degree of lipid accumulation and fewer pathological signs 





P. mume has been traditionally used as food and used in 
folk remedies and some of its pharmacological actions 
have been partly confirmed by modern science (Adachi et 
al., 2007), and the explorations of P. mume products 
development have achieved enormous popularity (Ng et 
al., 2005). Although a high intake of polyphenols and 
flavonoids significantly reduced the risk of obesity and 
hyperlipidemia (Woo et al., 2008), the physiological roles 
of PMSBE combined with L-carnitine as anti-obesity and 
in improving lipid profile are not clear. Squalene synthase 
plays an important role in the cholesterol biosynthetic 
pathway. Chlorogenic acid screened from P. mume fruits 
could inhibit the squalene synthase of pig liver with an 
IC50 level of 100 nM (Choi et al., 2007). Our previous 
study indicated that chlorogenic acid was the principal 
phenolic compounds of PMSBE, followed by 
neochlorogenic acid and cryptochlorogenic acid. 
The present study revealed that body weight gain of the 
HFD group mice were significantly higher than in the ND 
group, and the weight gain of PMC-1, PMC-2 and OR 
groups were normalized to the ND group (Table 1). In 
particular, the relative weight of the epididymal WAT and 
perirenal WAT of the HFD group mice were notably higher 
than any other group (ND, OR, PMC-1, or PMC-2) (Table 
2). There were no abnormalities in growth performance; 
the relative weight of the liver had no significantly higher 
in the HFD group compared with other groups. 
Interestingly, feed intake of all experimental groups had 
no significantly different. High Total-C or LDL-cholesterol 
concentrations are a risk factor for coronary heart disease 
(Woo et al., 2008). High-fat diets significantly increase the 
Total-C levels in the serum and liver as compared with the 
normal control diet in mice (Ono et al., 2006). The clinical 
complications of atherosclerosis could be diminished 
when serum lipid concentration is lowered by hypocholes- 
terolemic agents (Yang et al., 2006). The effects of 
polyphenols or flavonoids on lipid profile are very relevant 
to cardiovascular diseases. In this study, the average total 
phenolics content and the total flavonoids content of 
PMSB were 401.0 mg GAE/g and 355.5.5 mg RE/g, 
respectively. The anti-obesity functional formula (PMC) 
improved lipid profile by lowering serum Total-C, TG, 
LDL-C concentrations, and the ratio of LDL-C/ Total-C as 
compared with the HFD group (Table 3). The HDL-C 





increased compared with that of the HFD group. When 
mice were treated with PMC, a much smaller degree of 
lipid accumulation and fewer pathological signs were 
observed, as compared to the HFD group (Table 3). The 
PMC concentrations used in our study are proper concen- 
trations to see the physiological benefits without any side 
effects. 
Intestinal lipase inhibition using orlistat has been widely 
used in the pharmacotherapy of morbid obesity. However, 
the effects of orlistat on the secretion of appetite 
regulating gastrointestinal hormones and appetite 
sensations are still debated (Ellrichmann et al., 2008). 
The present study showed that PMC was comparable to 
orlistat in anti-obesity and improving lipid profile aspects 
of mice fed high-fat diet.  
In conclusion, various functional components, such as 
flavonoids and polyphenols in PMSBE, could play 
important roles in altering body fat and regulating lipid 
metabolism. This study may have important implications 
because it is the first report that P. mume stem bark 
extract has anti-obesity and improving lipid profile effects. 
How- ever, further study is needed to clarify that the 
anti-obesity and hypolipidemic activity could be due to 
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